diethylstilbestrol

Diethylstilbestrol (DES) is used in the treatment of menopausal and postmenopausal disorders.

Diethylstilbestrol dipropionate can be used in estrogen therapy of relapsed prostate cancer.

Diethylstilbestrol monoglucuronide is a reagent used in biochemical reactions.

Diethylstilbestrol/BSA is an antigen-adjuvant conjugate of Diethylstilbestrol and bovine serum albumin (BSA). Conjugating the antigen with a protein adjuvant can enhance antigen-specific antibody production in vaccine models. The conjugate does not disrupt protein folding or destroy primary epitopes and can enhance cross-presentation and antigen-specific T cell production.

Diethylstilbestrol/KLH is an antigen-adjuvant conjugate that links Diethylstilbestrol with keyhole limpet hemocyanin (KLH). This conjugation enhances the production of antigen-specific antibodies in vaccine models by coupling the antigen with a protein adjuvant. It does not affect protein folding or disrupt major epitopes, and it enhances cross-presentation and the production of antigen-specific T cells.

Amino-PEG10-amine is a PEG-based PROTAC linker employed for the conjugation of two mono diethylstilbestrol (DES)-based ligands. This compound offers an alternative approach to the synthesis of highly selective and active ER antagonists, which are crucial for the advancement of endocrine therapy in breast cancer treatment[1].

Amino-PEG11-amine, a polyethylene glycol (PEG)-based linker with 12 units, facilitates the conjugation of two mono diethylstilbestrol (DES)-based ligands. This strategy enhances the preparation of selective and potent estrogen receptor (ER) antagonists, offering an innovative approach for endocrine therapy in breast cancer treatment.

Trans-Diethyl-1,1,1',1'-Stilbestrol-3,3',5,5'-d8 is a deuterated compound of Trans-Diethyl-Stilbestrol. Trans-Diethyl-Stilbestrol has a CAS number of 56-53-1. Diethylstilbestrol is used in the treatment of menopausal and postmenopausal disorders.